William L Rocco

This inventor holds 8 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Incyte Corporation, Sanofi-Aventis, Sanofi Pharmaceuticals, Inc.. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William L Rocco. Retrieved from https://idiyas.com/inventor/william-l-rocco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 75.0

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 41(Granted Patents)

Company Filing History:

Sanofi Pharmaceuticals, Inc.

Years Active: 1998-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12318389 - Formulations of an AXL/MER inhibitor (2025-06-03),

2. 11918585 - Formulations of an AXL/MER inhibitor (2024-03-05),

3. 11241438 - Formulations of an AXL/MER inhibitor (2022-02-08),

4. 10166221 - Formulations of an LSD1 inhibitor (2019-01-01),

5. 7713548 - Amorphous solid dispersions (2010-05-11),

6. 7683062 - Crystalline form (2010-03-23),

7. 6197787 - Pharmaceutical formulations containing poorly soluble drug substances (2001-03-06),

8. 5776987 - Pharmaceutical suspension formulation (1998-07-07),

Title: Inventor William L Rocco: Pioneering AXL/MER Inhibitor Formulations

Introduction

William L Rocco, based in Reading, PA, is an accomplished inventor with a total of seven patents to his name. His innovative work primarily focuses on pharmaceutical formulations that have significant implications for treating critical diseases, such as cancer.

Latest Patents

Among his notable recent patents, Rocco has developed formulations of an AXL/MER inhibitor, which includes a range of dosage forms and methods of preparation. These formulations aim to provide therapeutic options for AXL/MER mediated diseases, showcasing Rocco's commitment to advancing medical science and patient care.

Career Highlights

William L Rocco has made impactful contributions to the pharmaceutical industry while working with prominent companies such as Incyte Corporation and Sanofi-Aventis. His expertise in drug formulation and development is underscored by his comprehensive patent portfolio, reflecting a deep dedication to innovation in the medical field.

Collaborations

Throughout his career, Rocco has collaborated with esteemed colleagues, including Nancy M Franson and Sharon M Laughlin. These partnerships have enhanced the research environment and facilitated his work on groundbreaking pharmaceutical solutions.

Conclusion

William L Rocco continues to make significant strides in the field of pharmaceutical formulations, particularly with his advancements in AXL/MER inhibitors. His dedication to innovation and collaboration has positioned him as a key figure in the fight against cancer and other related diseases.

Profile summary based on public USPTO records.